GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Benevolent AI (XAMS:BAI) » Definitions » Shares Outstanding (EOP)

Benevolent AI (XAMS:BAI) Shares Outstanding (EOP) : 124.44 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Benevolent AI Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Benevolent AI's shares outstanding for the quarter that ended in Dec. 2023 was 124.44 Mil.

Benevolent AI's quarterly shares outstanding increased from Jun. 2023 (119.99 Mil) to Dec. 2023 (124.44 Mil). It means Benevolent AI issued new shares from Jun. 2023 to Dec. 2023 .

Benevolent AI's annual shares outstanding increased from Dec. 2022 (119.99 Mil) to Dec. 2023 (124.44 Mil). It means Benevolent AI issued new shares from Dec. 2022 to Dec. 2023 .


Benevolent AI Shares Outstanding (EOP) Historical Data

The historical data trend for Benevolent AI's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Benevolent AI Shares Outstanding (EOP) Chart

Benevolent AI Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shares Outstanding (EOP)
Get a 7-Day Free Trial 145.13 145.13 119.99 119.99 124.44

Benevolent AI Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only 119.99 119.99 119.99 119.99 124.44

Competitive Comparison of Benevolent AI's Shares Outstanding (EOP)

For the Biotechnology subindustry, Benevolent AI's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Benevolent AI's Shares Outstanding (EOP) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Benevolent AI's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Benevolent AI's Shares Outstanding (EOP) falls into.



Benevolent AI Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Benevolent AI  (XAMS:BAI) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Benevolent AI Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of Benevolent AI's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


Benevolent AI (XAMS:BAI) Business Description

Traded in Other Exchanges
Address
4-8 Maple Street, London, GBR, W1T 5HD
Benevolent AI is a clinical-stage AI-enabled drug discovery company. It delivers novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform powers a growing in-house pipeline of over 20 drug programmes, spanning from target discovery to clinical studies, and it maintains commercial collaborations with pharmaceutical companies.

Benevolent AI (XAMS:BAI) Headlines

No Headlines